BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

361 related articles for article (PubMed ID: 17234991)

  • 21. Cyclooxygenase-2 inhibits UVB-induced apoptosis in mouse skin by activating the prostaglandin E2 receptors, EP2 and EP4.
    Chun KS; Akunda JK; Langenbach R
    Cancer Res; 2007 Mar; 67(5):2015-21. PubMed ID: 17332329
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lipopolysaccharide stimulates the production of prostaglandin E2 and the receptor Ep4 in osteoblasts.
    Shoji M; Tanabe N; Mitsui N; Tanaka H; Suzuki N; Takeichi O; Sugaya A; Maeno M
    Life Sci; 2006 Mar; 78(17):2012-8. PubMed ID: 16289620
    [TBL] [Abstract][Full Text] [Related]  

  • 23. EP2 and EP4 receptors differentially mediate MAPK pathways underlying anabolic actions of prostaglandin E2 on bone formation in rat calvaria cell cultures.
    Minamizaki T; Yoshiko Y; Kozai K; Aubin JE; Maeda N
    Bone; 2009 Jun; 44(6):1177-85. PubMed ID: 19233324
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prostaglandin E(2) protects intestinal tumors from nonsteroidal anti-inflammatory drug-induced regression in Apc(Min/+) mice.
    Hansen-Petrik MB; McEntee MF; Jull B; Shi H; Zemel MB; Whelan J
    Cancer Res; 2002 Jan; 62(2):403-8. PubMed ID: 11809688
    [TBL] [Abstract][Full Text] [Related]  

  • 25. High-glucose-induced prostaglandin E(2) and peroxisome proliferator-activated receptor delta promote mouse embryonic stem cell proliferation.
    Kim YH; Han HJ
    Stem Cells; 2008 Mar; 26(3):745-55. PubMed ID: 18096720
    [TBL] [Abstract][Full Text] [Related]  

  • 26. EP2/EP4 signalling inhibits monocyte chemoattractant protein-1 production induced by interleukin 1beta in synovial fibroblasts.
    Largo R; Díez-Ortego I; Sanchez-Pernaute O; López-Armada MJ; Alvarez-Soria MA; Egido J; Herrero-Beaumont G
    Ann Rheum Dis; 2004 Oct; 63(10):1197-204. PubMed ID: 15361371
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prostaglandins compromise basal forebrain cholinergic neuron differentiation and survival: action at EP1/3 receptors results in AIF-induced death.
    Jonakait GM; Ni L
    Brain Res; 2009 Aug; 1285():30-41. PubMed ID: 19555672
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibition of angiogenic tubule formation and induction of apoptosis in human endothelial cells by the selective cyclooxygenase-2 inhibitor 5-bromo-2-(4-fluorophenyl)-3-(methylsulfonyl) thiophene (DuP-697).
    Churchman A; Baydoun AR; Hoffman R
    Eur J Pharmacol; 2007 Nov; 573(1-3):176-83. PubMed ID: 17643408
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Acceleration of intestinal polyposis through prostaglandin receptor EP2 in Apc(Delta 716) knockout mice.
    Sonoshita M; Takaku K; Sasaki N; Sugimoto Y; Ushikubi F; Narumiya S; Oshima M; Taketo MM
    Nat Med; 2001 Sep; 7(9):1048-51. PubMed ID: 11533709
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inhibition of IL-6, TNF-alpha, and cyclooxygenase-2 protein expression by prostaglandin E2-induced IL-10 in bone marrow-derived dendritic cells.
    Harizi H; Norbert G
    Cell Immunol; 2004 Apr; 228(2):99-109. PubMed ID: 15219461
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Vitamin C exacerbates hydrogen peroxide induced apoptosis and concomitant PGE2 release in amnion epithelial and mesenchymal cells, and in intact amnion.
    Kumar D; Moore RM; Elkhwad M; Silver RJ; Moore JJ
    Placenta; 2004 Jul; 25(6):573-9. PubMed ID: 15135241
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Increases in retinovascular prostaglandin receptor functions by cyclooxygenase-1 and -2 inhibition.
    Hardy P; Bhattacharya M; Abran D; Peri KG; Asselin P; Varma DR; Chemtob S
    Invest Ophthalmol Vis Sci; 1998 Sep; 39(10):1888-98. PubMed ID: 9727412
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Stimulation of renin release by prostaglandin E2 is mediated by EP2 and EP4 receptors in mouse kidneys.
    Schweda F; Klar J; Narumiya S; Nüsing RM; Kurtz A
    Am J Physiol Renal Physiol; 2004 Sep; 287(3):F427-33. PubMed ID: 15113745
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Oncogenic potential of MEK1 in rat intestinal epithelial cells is mediated via cyclooxygenase-2.
    Komatsu K; Buchanan FG; Katkuri S; Morrow JD; Inoue H; Otaka M; Watanabe S; DuBois RN
    Gastroenterology; 2005 Aug; 129(2):577-90. PubMed ID: 16083714
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of prostaglandin E2 and prostaglandin I2 on PDGF-induced proliferation of LI90, a human hepatic stellate cell line.
    Hui AY; Cheng AS; Chan HL; Go MY; Chan FK; Sakata R; Ueno T; Sata M; Sung JJ
    Prostaglandins Leukot Essent Fatty Acids; 2004 Nov; 71(5):329-33. PubMed ID: 15380820
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prostaglandin E2 inhibits mineralization and enhances matrix metalloproteinase-13 in mature cementoblasts mainly via the EP4 pathway.
    Oka H; Miyauchi M; Sakamoto K; Kitagawa M; Noguchi K; Somerman MJ; Takata T
    Arch Oral Biol; 2008 Mar; 53(3):243-9. PubMed ID: 18045572
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Stimulation of prostaglandin E2 (PGE2) production by arachidonic acid, oestrogen and parathyroid hormone in MG-63 and MC3T3-E1 osteoblast-like cells.
    Coetzee M; Haag M; Claassen N; Kruger MC
    Prostaglandins Leukot Essent Fatty Acids; 2005 Dec; 73(6):423-30. PubMed ID: 16198098
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prostaglandin E2 (PGE2) downregulates interleukin (IL)-1alpha-induced IL-6 production via EP2/EP4 subtypes of PGE2 receptors in human periodontal ligament cells.
    Noguchi K; Maeda M; Ruwanpura SM; Ishikawa I
    Oral Dis; 2005 May; 11(3):157-62. PubMed ID: 15888106
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Roles of endogenous prostaglandins and cyclooxygenase isozymes in healing of indomethacin-induced small intestinal lesions in rats.
    Hatazawa R; Ohno R; Tanigami M; Tanaka A; Takeuchi K
    J Pharmacol Exp Ther; 2006 Aug; 318(2):691-9. PubMed ID: 16699067
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Colon carcinoma cell growth is associated with prostaglandin E2/EP4 receptor-evoked ERK activation.
    Pozzi A; Yan X; Macias-Perez I; Wei S; Hata AN; Breyer RM; Morrow JD; Capdevila JH
    J Biol Chem; 2004 Jul; 279(28):29797-804. PubMed ID: 15123663
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.